MacroGenics, Inc. (MGNX)
After hours:
| Previous close | 15.70 |
| Open | 14.93 |
| Bid | 14.34 x 100 |
| Ask | 14.40 x 200 |
| Day's range | 14.13 - 15.59 |
| 52-week range | 4.29 - 21.88 |
| Volume | |
| Avg. volume | 1,565,816 |
| Market cap | 898.994M |
| Beta (5Y monthly) | 2.11 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
We're Hopeful That MacroGenics (NASDAQ:MGNX) Will Use Its Cash Wisely
There's no doubt that money can be made by owning shares of unprofitable businesses. Indeed, MacroGenics ( NASDAQ:MGNX...
- Insider Monkey
MacroGenics, Inc. (NASDAQ:MGNX) Q4 2023 Earnings Call Transcript
MacroGenics, Inc. (NASDAQ:MGNX) Q4 2023 Earnings Call Transcript March 7, 2024 MacroGenics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. We will begin the MacroGenics 2023 Fourth Quarter Corporate Progress and Financial Results Conference Call in just […]
- Insider Monkey
12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
In this article, we discuss 12 most undervalued biotech stocks to buy according to hedge funds. If you want to skip our discussion on the biotech industry, head over to 5 Most Undervalued Biotech Stocks To Buy According To Hedge Funds. Fitch Ratings maintains a Neutral outlook for the global pharmaceutical and biotech industry in […]
